Business Description
Applied Genetic Technologies Corp
NAICS : 325414
SIC : 2836
ISIN : US03820J1007
Description
Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.7 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 1.14 | |||||
| Debt-to-EBITDA | -0.31 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -11.23 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -85.5 | |||||
| 3-Year EBITDA Growth Rate | -104 | |||||
| 3-Year EPS without NRI Growth Rate | -140.5 | |||||
| 3-Year FCF Growth Rate | -4.8 | |||||
| 3-Year Book Growth Rate | -48.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -58.26 | |||||
| 12-1 Month Momentum % | -81.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 1.4 | |||||
| Cash Ratio | 1.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -40.9 | |||||
| Shareholder Yield % | -214.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -20644.31 | |||||
| Net Margin % | -21610.46 | |||||
| FCF Margin % | -20785.23 | |||||
| ROE % | -163.21 | |||||
| ROA % | -84.83 | |||||
| ROIC % | -245.67 | |||||
| 3-Year ROIIC % | -296.35 | |||||
| ROC (Joel Greenblatt) % | -886.27 | |||||
| ROCE % | -116.01 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 65.6 | |||||
| PB Ratio | 1.51 | |||||
| Price-to-Tangible-Book | 1.64 | |||||
| EV-to-EBIT | -0.19 | |||||
| EV-to-Forward-EBIT | -0.18 | |||||
| EV-to-EBITDA | -0.19 | |||||
| EV-to-Forward-EBITDA | -0.18 | |||||
| EV-to-Revenue | 38.55 | |||||
| EV-to-Forward-Revenue | 0.7 | |||||
| EV-to-FCF | -0.19 | |||||
| Earnings Yield (Greenblatt) % | -526.32 | |||||
| FCF Yield % | -339.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AGTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Applied Genetic Technologies Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.325 | ||
| EPS (TTM) ($) | -1.42 | ||
| Beta | 0 | ||
| Volatility % | 94.95 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.009564 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | -81.68 | ||
| 52-Week Range ($) | 0.2303 - 2.825 | ||
| Shares Outstanding (Mil) | 67.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Applied Genetic Technologies Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Applied Genetic Technologies Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Applied Genetic Technologies Corp Frequently Asked Questions
What is Applied Genetic Technologies Corp(AGTC)'s stock price today?
The current price of AGTC is $0.39. The 52 week high of AGTC is $2.83 and 52 week low is $0.23.
When is next earnings date of Applied Genetic Technologies Corp(AGTC)?
The next earnings date of Applied Genetic Technologies Corp(AGTC) is .
Does Applied Genetic Technologies Corp(AGTC) pay dividends? If so, how much?
Applied Genetic Technologies Corp(AGTC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers